NEW YORK, April 4 /CNW/ - Executives from more than 80 public and private
healthcare companies, along with physicians, investors, and analysts are
attending the CIBC World Markets Annual Biotechnology and Specialty
Pharmaceuticals Conference, April 11-12, 2007, at New York's Millennium
Broadway Hotel.
    The highly anticipated conference will feature key insights into recent
developments in oncology, cardiovascular, auto-immune disorders, CNS/pain and
infectious diseases from leading mid and small cap companies in biotechnology,
life sciences and specialty pharmaceuticals. There will also be a panel
discussion on the diabetes and obesity epidemic, with leading authorities in
the field: F. Xavier Pi-Sunyer, MD, MPH; Stephen B. Richardson, F.A.C.P.,
F.RC.P; and Jay S. Skyler, MD, MACP. The panel discussion will focus on new
and current treatments of type 2 diabetes, as well as the overall landscape
for diabetes drug development.
    More information on the conference including presenting companies and an
agenda can be found at: http://conferences.cibcwm.com/biotech07/

    Important note about media attendance:

    This event is by invitation only; Media wishing to attend are required to
register in advance by calling (416) 980-4048. This event will also be
available via webcast at http://conferences.cibcwm.com/biotech07/ (enter code:
april07).

    CIBC World Markets is the wholesale and corporate banking arm of CIBC,
providing a range of integrated credit and capital markets products,
investment banking, and merchant banking to clients in key financial markets
in North America and around the world. We provide innovative capital solutions
and advisory expertise across a wide range of industries as well as top-ranked
research for our corporate, government and institutional clients.